TY - JOUR T1 - Bioluminescence Imaging of Adoptively Transferred Lymphocytes During Allogeneic Tumor Rejection JF - Anticancer Research JO - Anticancer Res SP - 6573 LP - 6576 VL - 35 IS - 12 AU - JURGITA JURŠĖNAITĖ AU - IRUTĖ GIRKONTAITĖ AU - MYKOLAS MAURICAS AU - RIMANTAS EIDUKEVIČIUS AU - ALMANTAS ŠIAURYS AU - DAINIUS CHARACIEJUS Y1 - 2015/12/01 UR - http://ar.iiarjournals.org/content/35/12/6573.abstract N2 - Aim: The aim of the present study was to analyze the survival, spatial distribution and proliferation of adoptively transferred lymphocytes in allogeneic tumor rejection. Materials and Methods: Transgenic β-actin-luc mice that express luciferase were sensitized against SL2 tumors and were used as lymphocyte donors to study the anti-tumor effect in SL2 tumor-bearing lymphocyte-deficient RAG−/− mice. Whole-body bioluminescence images of recipient mice were obtained to track the adoptively transferred lymphocytes. Proliferation of lymphocytes was estimated by quantification of photon emission. Results: T lymphocytes sensitized against allogeneic SL2 tumors cured the majority of SL2 tumor-bearing RAG−/− mice. Bioluminescence imaging showed that transferred T lymphocytes survived in the spleen and lymph nodes. Tumor rejection was associated with lymphocyte proliferation and migration to the tumor site. Conclusion: Sensitized T lymphocytes from transgenic β-actin-luc mice reject allogeneic SL2 tumors in RAG−/− mice and can be tracked in vivo using bioluminescence imaging. ER -